American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Arlington, Virginia: American Psychiatric Association, 2013.
Arnold, V.K., D. Feifel, C.Q. Earl, et al. “A 9-Week, randomized, double-blind, placebo-controlled, parallel-group, dose-finding study to evaluate the efficacy and safety of modafinil as treatment for adults with ADHD.” Journal of Attention Disorders May 2012.
Baker, A., Lee, N.K. & Jenner, L. (Eds) (2004). Models of intervention and care for psychostimulant users, 2nd Edition, National Drug Strategy Monograph Series No. 51.
Biederman, J., M.C. Monuteaux, T. Spencer, et al. “Do stimulants protect against psychiatric disorders in youth with ADHD? A 10-year follow-up study.” Pediatrics 124.1 July 2009: 71-78.
Bussing, R., D.M. Mason, L. Bell, P. Porter, and C. Garvan. “Adolescent outcomes of childhood attention-deficit/hyperactivity disorder in a diverse community sample.” Journal of the American Academy of Child and Adolescent Psychiatry 49.6 June 2010: 595-605.
Clay, R.A. “Easing ADHD without meds.” Monitor on Psychology 44.2 Feb. 2013.
Conners, C.K., D. Erhardt, J.N. Epstein, et al. “Self-ratings of ADHD symptoms in adults I: Factor structure and normative data.” Journal of Attention Disorders 3.3 Oct. 1999: 141-151.
Curatolo, P., E. D’Agati, and R. Moavero. “The neurobiological basis of ADHD.” Italian Journal of Pediatrics 36 (2010): 79.
Hines, J.L., T.S. King, and W.J. Curry. “The adult ADHD self-report scale for screening for adult attention deficit-hyperactivity disorder (ADHD).” Journal of the American Board of Family Medicine 25.6 Nov.-Dec. 2012: 847-853.
Ingram, S., L. Hechtman, and G. Morgenstern. “Outcome issues in ADHD: Adolescent and adult long-term outcome.” Mental Retardation and Developmental Disabilities Research Reviews 5.3 (1999): 243-250.
Lake, J. “Integrative management of ADHD: What the evidence suggests.” Psychiatric Times July 2010.
Martinez-Raga, J., A. Ferreros, C. Knecht, R. de Alvaro, and E. Carabal. “Attention-deficit hyperactivity disorder medication use: factors involved in prescribing, safety aspects and outcomes.” Therapeutic Advances in Drug Safety 8.3 March 2017: 87-99.
Maucieri, L. “ADHD hyperfocus: What is it and how to use it.” Psychology Today November 2014.
Millstein, R.B., T.E. Wilens, J. Biederman, and T.J. Spencer. “Presenting ADHD symptoms and subtypes in clinically referred adults with ADHD.” Journal of Attention Disorders 2.3 Oct. 1997: 159-166.
Mimouni-Bloch, A., A. Kachevanskaya, F.B. Mimouni, et al. “Breastfeeding may protect from developing attention-deficit hyperactivity disorder.” Breastfeeding Medicine May 2013.
Quintero, J., M. Loro, B. Jimenez, and N. Garcia Campos. “Evolutionary issues in attention deficit hyperactivity disorder (ADHD); from risk factors to comorbidity and social and academic impact.” Vertex 22.96 Mar.-Apr. 2011: 101-108.
Sagiv, S.K., J.N. Epstein, D.C. Bellinger, and S.A. Korrick. “Pre- and Postnatal Risk Factors for ADHD in a Nonclinical Pediatric Population.” Journal of Attention Disorders 17.1 Jan. 2013: 47-57.
Taylor, F.B., and J. Russo. “Efficacy of modafinil compared to dextroamphetamine for the treatment of attention deficit hyperactivity disorder in adults.” Journal of Child and Adolescent Psychopharmacology 10.4 Winter 2000: 311-320.
Thapar, A., and M. Rutter. “Do prenatal risk factors cause psychiatric disorder? Be wary of causal claims.” The British Journal of Psychiatry 195 (2009): 100-101.
Thapar, A., M. Cooper, R. Jefferies, et al. “What causes attention deficit hyperactivity disorder?” Archives of Disease in Childhood 97.3 March 2012: 260-265.
Weiss, M., and C. Murray. “Assessment and management of attention-deficit hyperactivity disorder in adults.” Canadian Medical Association Journal 168.6 Mar. 2003.
Wilens, T.E., S.V. Faraone, J. Biederman, and S. Gunawardene. “Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature.” Pediatrics 111.1 Jan. 2003: 179-185.